Companies / Evommune, Inc.
Evommune, Inc.
NYSE: EVMNCIK 2044725PALO ALTO, CA
Financials · FY2025
Ownership
36.3M shares outstanding · as of Aug 4, 2026
Ownership
| Insiders | 36.66% | 13,304,528 |
| Institutions | 74.78% | 27,139,538 |
| Public float | 0.00% | 0 |
Reported holdings exceed shares outstanding — public float shown as 0; some positions may overlap or lag.
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 10
View all →| Insider | % of shares | Shares |
|---|---|---|
LSP 7 Cooperatieve U.A.Director · 10% owner | 14.57% | 5,288,313 |
Verduyn-van Weegen Felice IsabelDirector · 10% owner | 14.57% | 5,288,313 |
RA Capital Management, L.P.Director | 7.47% | 2,710,293 |
Cohen David EDirector | 0.05% | 17,609 |
Kirsch Arthur SDirector | — | — |
Kolchinsky PeterDirector | — | — |
McGraw Benjamin F IIIDirector | — | — |
RA Capital Healthcare Fund LPDirector | — | — |
RA Capital Nexus Fund III, L.P.Director | — | — |
Shah Rajeev M.Director | — | — |
Institutional holders 73
View all →| Holder | Value | % of shares |
|---|---|---|
| $84.40M | 13.58% | |
| $80.34M | 9.63% | |
| $32.99M | 5.31% | |
| $32.48M | 5.23% | |
| $24.67M | 3.97% | |
| $22.41M | 3.61% | |
| $21.98M | 3.54% | |
| $21.93M | 3.53% | |
| $20.62M | 2.47% | |
| $20.22M | 2.42% |
Activity
InsidersInstitutions
What insiders are doing in this stock (Form 4).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 17, 2026 | Verduyn-van Weegen Felice Isabel Director | Grant | Common Stock | $10.00M | +359K +7.28% | 5,288,313 14.57% of shares | low |
| Feb 17, 2026 | LSP 7 Cooperatieve U.A. Director | Grant | Common Stock | $10.00M | +359K +7.28% | 5,288,313 14.57% of shares | low |
| Feb 17, 2026 | RA Capital Management, L.P. Director | Grant | Common Stock | $1000.0K | +36K +1.34% | 2,710,293 7.47% of shares | low |
| Jun 2, 2026 | Cohen David E Director | Sell | Common Stock | $110.3K | -5K -23.06% | 18,209 0.05% of shares | medium |
| Jun 2, 2026 | Cohen David E Director | Sell | Common Stock | $12.8K | -600 -3.30% | 17,609 0.05% of shares | low |
| Jun 2, 2026 | Cohen David E Director | Grant | Stock Option (Right to buy) | — | +16K | 15,673 0.04% of shares | low |
| Jun 2, 2026 | Kirsch Arthur S Director | Grant | Stock Option (Right to buy) | — | +16K | 15,673 0.04% of shares | low |
| Jun 2, 2026 | McGraw Benjamin F III Director | Grant | Stock Option (Right to buy) | — | +16K | 15,673 0.04% of shares | low |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Nan Fung Group Holdings Limited | Passive13G | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| EVMN | Common Stock | 30054Y107 |